Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial

Microarray patches (MAPs) have the potential to be a safer, more acceptable, easier-to-use, and more cost-effective means for the administration of vaccines than injection by needle and syringe. Here, we report findings from a randomized, partially double-blinded, placebo-controlled Phase I trial us...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Ben Baker, Imogen M. Bermingham, Indika Leelasena, Julian Hickling, Paul R. Young, David A. Muller, Angus H. Forster
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2023-11-01
سلاسل:	Vaccines
الموضوعات:	microarray patch (MAP) high-density microarray patch (HD-MAP) measles (M) rubella (R) vaccine Phase I
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/11/11/1725
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!